Webcasts

Changing Landscape of Therapies for Urothelial Carcinoma and Non-Muscle-Invasive Bladder Cancer with PD-1/PD-L1 Inhibitors, ADC and Recombinant Adenovirus Mediated Interferon-α2b
Released on 6/12/19
Expires on 6/12/20


Evolving Landscape of Treatment for Hepatocellular Carcinoma with Multi-Targeted Tyrosine Kinase Inhibitors and Immunotherapy
Released on 6/12/19
Expires on 6/12/20


Changing Landscape of Targeted and Immunotherapies for Genitourinary Cancers
Released on 6/12/19
Expires on 6/12/20


Changing Treatment Landscape of Metastatic Head and Neck Squamous Cell Carcinoma with Anti-PD-1/PD-L1 Agents
Released on 6/10/19
Expires on 6/10/20


New Paradigms in the Treatment of Acute Lymphoblastic Leukemia, Chronic Lymphocytic Leukemia, Acute Myeloid Leukemia and Chronic Myeloid Leukemia
Released on 5/13/19
Expires on 5/13/20


Optimizing Outcomes in Patients with Malignant Melanoma Treated with Targeted Agents, Checkpoint Inhibitors and Oncolytic Viral Therapies
Released on 12/30/18
Expires on 12/30/19


Emerging Novel PI3K Inhibitors, Anti-CD20 mAb and Combination Therapy Options for Follicular Lymphoma
Released on 12/30/18
Expires on 12/30/19


Changing Landscape of Treatment Strategies of TKI Interruptions, Discontinuations and Switching in Patients with Chronic Myeloid Leukemia
Released on 12/30/18
Expires on 12/30/19


Update on Treatment Options for Acute Lymphoblastic Leukemia with An Emphasis on CD19, CD22 Monoclonal Antibodies and Anti-CD19 CAR T-cell Therapy
Released on 12/30/18
Expires on 12/30/19


Changing Treatment Paradigms with Immunotherapy and Targeted Therapy in Advanced Non-Small-Cell Lung Cancer and Head & Neck Cancer
Released on 11/7/18
Expires on 11/7/19


Emerging Treatment Options for Genomic Subgroups of Acute Myeloid Leukemia with IDH1/2, FLT3 and CD33 Targeted Agents
Released on 10/19/18
Expires on 10/19/19


Emerging Strategies in Novel Targeted Therapies for Genitourinary Cancers (Prostate Cancer, Renal Cell Carcinoma and Urothelial Bladder Carcinoma)
Released on 9/28/18
Expires on 9/28/19


Emerging Novel Anti-CD20 mAb, PI3K Inhibitors and Combination Therapy Options for Follicular Lymphoma
Released on 8/15/18
Expires on 8/15/19


Mapping the Future Treatment Options with Multitargeted TKIs and Checkpoint Inhibitors for Metastatic Renal Cell Carcinoma
Released on 8/15/18
Expires on 8/15/19


Mapping the Current and Future Treatment Options for Advanced Soft Tissue Sarcoma Including Liposarcoma and Leiomyosarcoma
Released on 8/15/18
Expires on 8/15/19


7th Annual Symposium on Current Strategies in the Treatment of Hodgkins Lymphoma, B-cell Lymphoma, Multiple Myeloma and Leukemia
Released on 7/2/18
Expires on 7/2/19


Immunotherapy with Anti-PD-1/PD-L1 Agents Are New Effective Therapies for Recurring and/or Metastatic Squamous Cell Carcinoma of the Head and Neck
Released on 6/29/18
Expires on- 6/29/19


Advances in the Treatment of Acute Lymphoblastic Leukemia with An Emphasis on CD22 and CD19 Monoclonal Antibodies
Released on 4/25/18
Expires on 4/25/19


Emerging Strategies in the Diagnosis, Treatment and the Concept of Treatment-free Remission in Chronic Myeloid Leukemia
Released on 12/28/17
Expires on 12/28/18


Changing Landscape of Novel Combination Therapies for Patients with Newly Diagnosed, Risk Stratified and Relapsed/Refractory Multiple Myeloma
Released on 12/20/17
Expires on 12/20/18


Emerging Checkpoint Inhibitor and Combination Based Therapies for Relapsed or Refractory Hodgkin's Lymphoma
Released on 12/20/17
Expires on 12/20/18


Update on Treatment Options for Leukemia: Acute Lymphoblastic Leukemia, Chronic Lymphocytic Leukemia, Acute Myeloid Leukemia and Chronic Myeloid Leukemia
Released on 11/30/17
Expires on 11/30/18


Novel Therapeutic Approaches of EGFR-, ALK-rearranged Targeted Therapies and Immunotherapy of Lung Cancer
Released on 10/6/17
Expires on 10/6/18


Emerging Strategies in Targeted Therapy of Advanced Gastric or Gastro-esophageal Junction Adenocarcinoma
Released on 9/13/17
Expires on 9/13/18


Emerging Treatment Option with CDK 4/6 Inhibitors for Hormone Receptor-positive Breast Cancer: Insight into Clinical Activity and Safety Profile
Released on 8/8/17
Expires on 8/8/18


6th Annual Symposium on Current Strategies in the Treatment of Hodgkins Lymphoma, B-cell Lymphoma, Multiple Myeloma and Leukemia
Released on 7/28/17
Expires on 7/28/18


Emerging Strategies in the Treatment of Metastatic Urothelial Bladder Carcinoma: Outlook for 2017
Released on 7/26/17
Expires on 7/26/18


Emerging Treatment Options for Metastatic Renal Cell Carcinoma
Released on 5/11/17
Expires on 5/11/18


Changing Paradigms in the Diagnosis and Treatment of Multiple Myeloma
Released on 3/10/2017
Expired on 3/10/2018


Update on Immunotherapy Options for Non-Small Cell Lung Cancer
Released on 3/6/17
Expires on 3/6/18


Practice Changing Shift in Treatment Strategies for Advanced Soft Tissue Sarcoma, Liposarcoma and Leiomyosarcoma
Released on 2/16/17
Expires on 2/16/18


Practice Changing Treatment with CDK 4/6 Inhibitors for Hormone Receptor‐Positive Breast Cancer
Released on 12/30/16
Expires on 12/30/17


Emerging Strategies in Treatment of Hodgkin Lymphoma and Non‐Hodgkin Lymphoma
Released on 12/29/16
Expires on 12/29/17


Emerging Immunotherapy Options for Relapsed or Refractory Hodgkin's Lymphoma
Released on 12/20/16
Expires on 12/20/17


Novel Therapeutic Approaches for Patients with Squamous Cell Carcinoma of the Head and Neck
Released on 11/15/16
Expires on 11/15/17


Novel Treatment Approaches for Non-Small-Cell Lung Cancer: A 2016 Update
Released on 10/25/16
Expires on 10/25/17


Novel Therapeutic Options for Acute Lymphoblastic Leukemia
Released on 7/21/16
Expires on 7/21/17


Advances in the Treatment Options for Liposarcoma/Leiomyosarcoma and Soft Tissue Sarcoma
Released on 7/21/16
Expires on 7/21/17


Novel Therapies for Malignant Melanoma: Immune Checkpoint Inhibitors, Targeted BRAF Inhibitors and Oncolytic Viral Therapy Approaches
Released on 7/7/16
Expires on 7/7/17


Emerging Strategies in the Treatment of Chronic Lymphocytic Lymphoma
Released on 7/1/16
Expires on 7/7/17


Personalized, Genotype-directed Therapy for Advanced Non-Small Cell Lung Cancer
Released on 6/30/2016
Expires on 6/30/2017


Changing Landscape in the Treatment of Metastatic Renal Cell Carcinoma and Bladder Cancer: Newer Insights
Released on 6/30/2016
Expires on 6/30/2017


Molecular Prognostic and Predictive Biomarkers Based Targeted Treatment of Colorectal Cancer
Released on 6/30/2016
Expires on 6/30/2017


5th Annual Symposium on Current Strategies in the Management of B-cell Lymphomas, T-cell Lymphomas, Multiple Myeloma and Leukemia
Released on 6/27/2016
Expires on 6/27/2016